Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04968249 · ClinicalTrials.gov registry record

Michigan Early Disease Progression Cohort

A clinical trial of COPD, sponsored by University of Michigan.

Active
Registry status
200
Enrollment target
1
Study location

NCT04968249 is a study of COPD that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 200 participants, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04968249, a study of COPD, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

The aim of this project is to develop a disease progression cohort within the University of Michigan Health System to capture pulmonary function, symptom assessments and quantitative imaging among patients at risk for or with an established diagnosis of COPD, focusing however on "early" COPD (age 30-55 and GOLD stage 0,1, 2, and prism).

Conditions Studied

Interventions

  • OTHER Observational

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-07-30
Est. Completion 2027-03

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04968249

The ClinicalTrials.gov registry entry for NCT04968249 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (92% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT04968249 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04968249 about?

NCT04968249 is a clinical study titled "Michigan Early Disease Progression Cohort". The aim of this project is to develop a disease progression cohort within the University of Michigan Health System to capture pulmonary function, symptom assessments and quantitative imaging among patients at risk for or with an established diagnosis of COPD, focusing however on "early" COPD (age 30...

What is the current status of trial NCT04968249?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2021-07-30. Estimated completion is 2027-03.

What conditions does trial NCT04968249 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT04968249?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT04968249?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04968249 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.